Post-ischemic myocardial inflammatory response: a complex and dynamic process susceptible to immunomodulatory therapies
NJ Pluijmert, DE Atsma, PHA Quax - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Following acute occlusion of a coronary artery causing myocardial ischemia and
implementing first-line treatment involving rapid reperfusion, a dynamic and balanced …
implementing first-line treatment involving rapid reperfusion, a dynamic and balanced …
Perioperative cardioprotection: general mechanisms and pharmacological approaches
C Torregroza, A Raupach, K Feige… - Anesthesia & …, 2020 - journals.lww.com
Cardioprotection encompasses a variety of strategies protecting the heart against
myocardial injury that occurs during and after inadequate blood supply to the heart during …
myocardial injury that occurs during and after inadequate blood supply to the heart during …
Beneficial effects of oridonin on myocardial ischemia/reperfusion injury: insight gained by metabolomic approaches
J Zhang, Y Zhou, Y Sun, H Yan, W Han, X Wang… - European Journal of …, 2019 - Elsevier
Oridonin is a diterpenoid isolated from Rabdosia rubescens (Hemsl.) Hara, a well-known
herbal tea in China with many health benefits. To provide a better understanding of the …
herbal tea in China with many health benefits. To provide a better understanding of the …
Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosis
Morphine is routinely used for pain management in heart failure patients. However,
extended morphine exposure associates with major adverse cardiovascular events. Reports …
extended morphine exposure associates with major adverse cardiovascular events. Reports …
Morphine deteriorates cisplatin-induced cardiotoxicity in rats and induces dose-dependent cisplatin chemoresistance in MCF-7 human breast cancer cells
AAK El-Sheikh, Z Khired - Cardiovascular Toxicology, 2021 - Springer
Morphine (MOR) is a strong analgesic that is often used in treatment of severe pains during
cancer treatment, and thus might be concomitantly used with anticancer drugs as cisplatin …
cancer treatment, and thus might be concomitantly used with anticancer drugs as cisplatin …
[HTML][HTML] Возраст-ассоциированный уровень маркеров фиброза миокарда и хемокинов у пациентов с острым коронарным синдромом
ОА Осипова, АИ Головин, ОН Белоусова… - Кардиоваскулярная …, 2021 - cyberleninka.ru
Цель. Изучить возраст-ассоциированные особенности концентрации маркеров
фиброза и моноцитарного хемоаттрактантного белка 1 (МСР-1) у больных острым …
фиброза и моноцитарного хемоаттрактантного белка 1 (МСР-1) у больных острым …
Post-infarct morphine treatment reduces apoptosis and myofibroblast density in a rat model of cardiac ischemia-reperfusion
SF Rajani, M Faghihi, A Imani - European Journal of Pharmacology, 2020 - Elsevier
Following myocardial ischemia, the cardiac tissue undergoes both, physiological and
pathological changes to compensate the initial loss of function. Long-term continuous …
pathological changes to compensate the initial loss of function. Long-term continuous …
Perioperative cardioprotection—From bench to bedside: Current experimental evidence and possible reasons for the limited translation into the clinical setting
C Torregroza, S Roth, K Feige, G Lurati Buse… - Der Anaesthesist, 2021 - Springer
Background Perioperative cardioprotection aims to minimize the consequences of
myocardial ischemia reperfusion injury. These strategies appear particularly relevant for …
myocardial ischemia reperfusion injury. These strategies appear particularly relevant for …
[HTML][HTML] Morphine in acute coronary syndrome and myocardial infarction: pro et contra
GA Ignatenko, GG Taradin, IV Rakitskaya… - Health, Food & …, 2021 - hfb-mgupp.com
The review summarizes the current literature data on the use of the morphine in patients with
acute coronary syndrome and myocardial infarction. It briefly reports on the possibility of …
acute coronary syndrome and myocardial infarction. It briefly reports on the possibility of …
[HTML][HTML] Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome
OA Osipova, AI Golovin… - Cardiovascular …, 2021 - cardiovascular.elpub.ru
Aim. To study age-related specifics of the concentration of fibrosis markers and monocyte
chemotactic protein-1 (MCP-1) in patients with ST-segment elevation acute coronary …
chemotactic protein-1 (MCP-1) in patients with ST-segment elevation acute coronary …